Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessCOVID-19

Changes in the clinical distribution and antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital before and after the COVID-19 pandemic

BMC Infectious Diseases·

Yan Yang, Chunyan Long, Ye He, Tao Huang, Zailiang Yang, Ling Zhang, Guoqun Tan, Yang Liu

DOI
10.1186/s12879-026-14277-4
PMID
PMCID
OpenAlex
Study type
Journal article
Publisher
Springer Science and Business Media LLC
Article type
journal-article
Integrity
current

Why this research matters now

The findings are positioned to inform antibiotic stewardship and hospital infection control by highlighting temporal shifts in K. pneumoniae epidemiology and resistance patterns around the pandemic transition.

01

Structured evidence summary

Research question

The study examined how the isolation and antibiotic resistance profiles of Klebsiella pneumoniae shifted across pre-, mid-, and post-COVID-19 pandemic periods within a single Chinese tertiary hospital.

Study design

A retrospective laboratory-based analysis of K. pneumoniae isolates collected at one tertiary hospital in Chongqing, stratified into three time periods (2017–2019, 2020–2022, 2023–2025) and analyzed using GraphPad Prism 10.1.2 and WHONET 5.6.

Population and setting

Clinical specimens yielding K. pneumoniae at a tertiary hospital in Chongqing, with sputum, secretions, and urine as the leading specimen sources; patient age distributions were compared between carbapenem-resistant and carbapenem-susceptible groups.

Main findings

A total of 883 K. pneumoniae strains were identified, representing 20.8% of Gram-negative isolates, with the isolation rate significantly higher in the post-pandemic phase. Carbapenem-resistant K. pneumoniae rates were 3.0%, 12.2%, and 5.0% across the three periods, while extensively drug-resistant K. pneumoniae rates were 2.4%, 8.3%, and 4.7%, respectively. Resistance to several agents (ceftazidime, cefepime, ciprofloxacin, imipenem, and trimethoprim-sulfamethoxazole) rose in the mid-pandemic period and partially declined post-pandemic, with imipenem resistance increasing more than threefold mid-pandemic compared with pre-pandemic levels.

Public-health relevance

The findings are positioned to inform antibiotic stewardship and hospital infection control by highlighting temporal shifts in K. pneumoniae epidemiology and resistance patterns around the pandemic transition.

Important limitations

No explicit limitations were stated in the supplied abstract. This summary is limited to the supplied single-article abstract and metadata; the full original paper is required for decision-grade interpretation.

GIDS interpretation

The article is thematically discoverable under antimicrobial resistance and COVID-19-related topics; no connection to a live surveillance signal is established from the supplied evidence.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 6 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseaddresses topichas pathogen typestudied population settingstudies pathogenuses study design